PAOG Completes Compliance Updates In Conjunction With Cannabis Biopharma Revitalization Initiative

Sandusky, OH – August 27, 2020 –  — PAO Group, Inc. (OTC PINK: PAOG) today announced having published all required filings necessary to meet the OTC Markets “Current Information” reporting standard. Yesterday, the company published the final compliance requirement, a legal opinion, following the publications of its Q1 2020 and Q2 2020 report earlier this week and the 2019 annual report published late last week.  The company anticipates the “Current Information” status to soon be reflected on the OTC Markets website following an OTC Markets review.

PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the cannabis biopharmaceutical sector. The company acquired a cannabis cultivation business from Puration, Inc. (PURA).  From Kali-Extracts (KALY), PAOG acquired a proprietary CBD extract derived from a patented extraction process and formulated for the treatment of respiratory disorders. The revitalization strategy included updating the company’s financial statements to make the company compliant with the OTC Markets’ “Current Information” reporting standard.

Goldman Small Cap Research is anticipated to update a recently published analyst report once PAOG has achieved the “Current Information” standard.

See the current Goldman Small Cap Research Analyst Report:

Under The Radar CBD Pharma Player Could Offer Major Upside

­Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.


Contact Us:
Jim DiPrima




Mcap MediaWire - Costumer Service

Translate »